Maria Betancourt
New York, NYNPI 1831282474
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 34.8% of the total. Reporting peaked in 2019 at $780 and has fallen 59.0% since, to $320 in 2021.
Across 83 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$574
- Lupin Inc.$262
- Amgen$232
- Merck$142
- Evofem Biosciences, Inc.$83
- Daiichi Sankyo Inc.$61
- plus $292 from 10 others
Across 49 payments — averaging $2156.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$63K
- Mitsubishi Tanabe Pharma Development America, Inc.$27K
- Bayer$16K
What the payments were for
- Food & beverage$1,60898%
- Education$392%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $574 |
| Lupin Inc. | 14 | $262 |
| Amgen | 10 | $232 |
| Merck | 8 | $142 |
| Evofem Biosciences, Inc. | 5 | $83 |
| Daiichi Sankyo Inc. | 3 | $61 |
| Bayer | 2 | $40 |
| AMAG Pharmaceuticals, Inc. | 2 | $39 |
| Vertical Pharmaceuticals, LLC | 2 | $38 |
| Mylan Pharmaceuticals Inc. | 2 | $36 |
| Mission Pharmacal Company | 1 | $26 |
| Avion Pharmaceuticals | 2 | $26 |
| Therapeuticsmd, Inc. | 1 | $23 |
| Duchesnay USA Incorporated | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Myovant Sciences Inc. | 1 | $20 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.